On January 31, 2025, Judge Charles Eskridge of the U.S. District Court for the Southern District of Texas denied the FTC’s request for a preliminary injunction in Tempur Sealy International,…
Compass Lexecon’s client Express Scripts defeated a motion for certification of putative classes of direct and indirect purchasers of the specialty drug Acthar.
Compass Lexecon worked closely with the merging parties on this matter, starting with a team advising Horizon on the merger (led by Compass Lexecon expert Mark Israel) and proceeding to the…
Compass Lexecon’s staff includes more than 850 employees, including professional consultants, analysts, and practice support personnel that span 25 offices across the globe.
